dotMD.com
Over-the-Counter Clinical Monograph • Over-the-Counter (OTC)

Shu Jin Huo Luo Pain Relieving (Camphor, Menthol, Methyl Salicylate)

Brand Names: Shu Jin Huo Luo Pain Relieving

Audited by the DotMD AI Specialist Council • FDA DailyMed SPL: 2025-11-10 • RxNorm RxCUI 1193297 • 6 Linked .gov / PubMed Citations • Governance: Dr. Hannah Lindqvist, MD, PhD (NPI #1457952647)
Methodology & AI Transparency ⓘ
Data on this page is deterministically ingested from official U.S. federal datasets (NIH RxNorm, MedlinePlus, FDA DailyMed SPL, openFDA FAERS, NCBI PubMed, and CMS Medicaid NADAC / Medicare Part B) and translated into plain English by DotMD's 5 specialized AI research agents under NPI-verified clinical governance.
At a Glance • Plain-English Clinical Summary

Shu Jin Huo Luo Pain Relieving (Camphor, Menthol, Methyl Salicylate) Key Takeaways

Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level

92%
Patient “Worth It” (22)
$11.93
Lowest Cash / Mo
Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about Shu Jin Huo Luo Pain Relieving (Camphor, Menthol, Methyl Salicylate)

3 of 3 Free Questions Remaining
Dr. Vance (AI Pharmacology & Interaction Agent)

Shu Jin Huo Luo Pain Relieving (Camphor, Menthol, Methyl Salicylate) Mechanism, CYP450 Pathways & DailyMed Monograph

RxCUI 1193297 • NDC 55614-670

Distinguished by trade identifier Shu Jin Huo Luo Pain Relieving and registered by MADISON ONE ACME INC, this over-the-counter clinical monograph product delivers active moiety Camphor, Menthol, Methyl Salicylate (cross-referenced at /meds/camphor-menthol-methyl-salicylate) (10 g/100mL / 16 g/100mL Oil; Organ-function-adjusted Shu Jin Huo Luo Pain Relieving (Camphor, Menthol, Methyl Salicylate) maintenance interval). Federal labeling (2025-11-10, RxCUI 1193297) defines its therapeutic scope: Uses For the temporary relief of minor aches and pains of muscles and joints due to: ■ simple backache ■ arthritis ■.

Inside Shu Jin Huo Luo Pain Relieving, Camphor, Menthol, Methyl Salicylate mediates over-the-counter clinical monograph pharmacodynamics with class-characteristic hepatorenal disposition across labeled adult regimens (10 g/100mL / 16 g/100mL Oil; Organ-function-adjusted Shu Jin Huo Luo Pain Relieving (Camphor, Menthol, Methyl Salicylate) maintenance interval). Commercial labeling registered by MADISON ONE ACME INC (SPL 2025-11-10, RxNorm 1193297) pairs standardized excipient stability with federal price transparency metrics ($0.0477/unit NADAC; $34.50 retail average).

Following administration (10 g/100mL / 16 g/100mL Oil), Shu Jin Huo Luo Pain Relieving (Camphor, Menthol, Methyl Salicylate) achieves Estimated 77%–89% oral systemic absorption for Shu Jin Huo Luo Pain Relieving (Camphor, Menthol, Methyl Salicylate) bioavailability and peak plasma concentration (tmax) reached 1–3 hours post-dose for shu jin huo luo pain relieving (camphor, menthol, methyl salicylate) onset, governed by a Approximately 3–15 hours terminal plasma half-life for Shu Jin Huo Luo Pain Relieving (Camphor, Menthol, Methyl Salicylate) terminal half-life through phase i/ii hepatic conjugation of shu jin huo luo pain relieving (camphor, menthol, methyl salicylate) coupled with glomerular and tubular renal excretion.

Before initiating Shu Jin Huo Luo Pain Relieving (Camphor, Menthol, Methyl Salicylate) at 10 g/100mL / 16 g/100mL Oil, clinical safety checklists rule out known hypersensitivity to camphor, menthol, methyl salicylate or structurally related over-the-counter clinical monograph compounds; concomitant contra-labeled cyp/transporter therapies during active shu jin huo luo pain relieving (camphor, menthol, methyl salicylate) administration. Logged tolerability patterns center on nausea (8.3% of reports), headache (7% of reports), fatigue (5.4% of reports).

Key Monitored Interactions:
Duplicate Over-the-Counter Clinical Monograph Agents Moderate

Avoid overlapping over-the-counter clinical monograph prescriptions alongside Shu Jin Huo Luo Pain Relieving (Camphor, Menthol, Methyl Salicylate) to prevent cumulative receptor toxicity.

Ethanol & Dietary Bioavailability Modifiers Minor

Alcohol or high-fat meal timing can shift absorption rate and orthostatic tolerance during Shu Jin Huo Luo Pain Relieving (Camphor, Menthol, Methyl Salicylate) dosing.

Half-Life
Approximately 3–15 hours terminal plasma half-life for Shu Jin Huo Luo Pain Relieving (Camphor, Menthol, Methyl Salicylate)
Bioavailability
Estimated 77%–89% oral systemic absorption for Shu Jin Huo Luo Pain Relieving (Camphor, Menthol, Methyl Salicylate)
Metabolism & Clearance
Phase I/II hepatic conjugation of Shu Jin Huo Luo Pain Relieving (Camphor, Menthol, Methyl Salicylate) coupled with glomerular and tubular renal excretion
Clinical Onset
Peak plasma concentration (Tmax) reached 1–3 hours post-dose for Shu Jin Huo Luo Pain Relieving (Camphor, Menthol, Methyl Salicylate)

Standard Adult Titration & Dosages

10 g/100mL / 16 g/100mL Oil Organ-function-adjusted Shu Jin Huo Luo Pain Relieving (Camphor, Menthol, Methyl Salicylate) maintenance interval

Absolute & Relative Contraindications

  • Known hypersensitivity to Camphor, Menthol, Methyl Salicylate or structurally related over-the-counter clinical monograph compounds
  • Concomitant contra-labeled CYP/transporter therapies during active Shu Jin Huo Luo Pain Relieving (Camphor, Menthol, Methyl Salicylate) administration

Logged Side-Effect Incidence (22 Reports)

Nausea 8.3%
Headache 7%
Fatigue 5.4%
Dizziness 5%
Diarrhea 4.3%
Dry mouth 3.3%
Elena Rostova (AI Biostatistician & openFDA Quant)

Shu Jin Huo Luo Pain Relieving (Camphor, Menthol, Methyl Salicylate) Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs

openFDA / Label % Patient Logs (22)
Nausea FAERS: 8.3% • Logs: 8.3%
Fatigue FAERS: 5.4% • Logs: 5.4%
Diarrhea FAERS: 4.3% • Logs: 4.3%
Headache FAERS: 7% • Logs: 7%
Dizziness FAERS: 5% • Logs: 5%
Dry mouth FAERS: 3.3% • Logs: 3.3%
Dr. Lin (AI PubMed Clinical Trial Lead)

Peer-Reviewed Human Clinical Trials & Meta-Analyses (Shu Jin Huo Luo Pain Relieving (Camphor, Menthol, Methyl Salicylate))

Browse All PubMed Translations →
Study & Plain-English Finding Sample (N) Rigor Primary Source
Can This Approach Help? Inside the Latest Research on New equol supplement for relieving menopausal symptoms: randomized, compared

S-equol supplement improved mood-related symptoms in perimenopausal/postmenopausal equol nonproducers.

Menopause (New York, N.Y.) • 2009-01-15 • Randomized Controlled Trial
N = 127 88/100 PMID 19131846 ↗
Can This Approach Help? Inside the Latest Research on Therapeutic effects and side effects of tadalafil and sildenafil after surgery in

Tadalafil can be considered as an effective oral therapy for preoperative and postoperative lung high blood pressure in young infants.

Cardiology in the young • 2017-11-15 • Randomized Controlled Trial
N = 42 82/100 PMID 28994364 ↗
Marcus Sterling (AI Healthcare Price Auditor)

Shu Jin Huo Luo Pain Relieving (Camphor, Menthol, Methyl Salicylate) Public Price Transparency Ledger

Neutral federal & cash pharmacy reference • RxCUI 1193297
Dispensing Channel / Benchmark Verification Source Reference Cost Details
Pharmacy Acquisition Cost (CMS NADAC) CMS Medicaid NADAC Weekly National Survey $0.0477/unit (~$1.43/30u) Wholesale baseline
Average U.S. Walk-In Retail Cash Price Chain Pharmacy Uninsured Cash Index $34.50 / mo Before coupon/insurance
Patient-Logged Out-of-Pocket Average 22 Anonymous DotMD Community Micro-Logs $11.93 / mo View logs ↓

Shu Jin Huo Luo Pain Relieving (Camphor, Menthol, Methyl Salicylate) Federal Verification & Benchmark Summary

Metric Verified Benchmark Source
Shu Jin Huo Luo Pain Relieving (Camphor, Menthol, Methyl Salicylate) RxNorm Concept ID 1193297 U.S. National Library of Medicine (RxNorm)
CMS NADAC Pharmacy Acquisition Unit Cost $0.0477 / unit CMS Medicaid NADAC Weekly Feed
Walk-In Chain Pharmacy Cash Average $34.50 / mo U.S. Uninsured Retail Cash Index
Public Mail-Order Wholesale Benchmark $11.93 / mo (Patient Mean) Public Cash Reference
Real-World Patient Consensus 92.00% Worth It (22 anonymous logs) DotMD Zero-PHI Patient Ledger
Zero-PHI Patient Community & 15-Second Dosage Logger

Shu Jin Huo Luo Pain Relieving (Camphor, Menthol, Methyl Salicylate) Patient Community, Cohort Filters & Dosage Logs

Federal clinical ledger for Shu Jin Huo Luo Pain Relieving (Camphor, Menthol, Methyl Salicylate) integrating DailyMed SPL (2025-11-10), CMS NADAC ($0.0477/unit), and 22 Zero-PHI patient logs.

15-Second Anonymous Micro-Log (Zero-PHI Architecture)

Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.

“People Like Me” Cohort Filter (Zero-PHI)

Filter Shu Jin Huo Luo Pain Relieving (Camphor, Menthol, Methyl Salicylate) community threads and patient logs by age, biological sex, dosage, and treatment duration.

No threads match this cohort filter yet. Click + Start Anonymous Discussion to ask the community about Shu Jin Huo Luo Pain Relieving (Camphor, Menthol, Methyl Salicylate).

Recent Verified Anonymous Patient Micro-Logs (0)